Businessweek

Palomar Medical Technologies Inc. announced unaudited consolidated financial results for the first quarter ended March 31, 2013. For the quarter, total revenue was $23,223,059 against $18,999,803 a year ago. Loss from operations was $938,701 against $2,320,619 a year ago. Loss before income taxes was $1,299,423 against $2,219,814 a year ago. Net loss was $1,111,728 or $0.06 per diluted share against $2,291,792 or $0.12 per diluted share a year ago.

Levi & Korsinsky notified investors of Palomar Medical Technologies Inc. of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the company in connection with the sale of the company to Cynosure Inc. A complaint was filed in Massachusetts state court. Under the terms of the transaction, Palomar shareholders will receive $6.825 in cash and $6.825 in Cynosure common stock for each share of Palomar stock they own. The transaction has a total approximate value of $294 million. The claims concern whether the Palomar board of directors breached their fiduciary duties to stockholders by failing to adequately shop the company before entering into this transaction and whether Cynosure Inc. is underpaying for Palomar shares, thus unlawfully harming Palomar stockholders. In particular, at least one analyst set a price target for Palomar stock at $14.50 per share.

Palomar Medical Technologies Inc., Q1 2013 Earnings Call, May 02, 2013

To discuss definitive agreement definitive agreement, pursuant to which Cynosure will acquire Palomar in a cash and stock transaction

Palomar Medical Technologies Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, the company reported total revenues of $23,428,227 against $22,962,192 for the same period a year ago. Income from operations was $2,255,229 against $2,563,492 for the same period a year ago. Income before income taxes was $1,787,656 against loss before income taxes of $1,743,284 for the same period a year ago. Net income was $2,266,789 or $0.12 basic and diluted per share against net loss of $1,936,642 or $0.10 basic and diluted per share for the same period a year ago. For the full year, the company reported total revenues of $80,573,235 against $103,436,868 for the same period a year ago. Loss from operations was $5,991,405 against income from operations of $10,737,682 for the same period a year ago. Loss before income taxes was $5,686,629 against income before income taxes of $11,534,392 for the same period a year ago. Net loss was $6,171,159 or $0.33 diluted per share against net income of $7,428,429 or $0.39 basic and diluted per share for the same period a year ago.